1470nm Laser: How Was the "Gold Standard" for Minimally Invasive Varicose Vein Treatment Forged?

In the field of minimally invasive treatment for varicose veins, technological iteration never ceases. The 1940nm laser has entered the clinical landscape with highlights of "higher water absorption peak and less postoperative pain," sparking considerable discussion. However, whether a technology becomes the "gold standard" depends not only on its theoretical advantages but also on its long-term stability in real-world studies, its universality across different vascular conditions, and safety data tested over more than a decade.

This article focuses on the 1470nm laser, reviewing authoritative literature to answer a core question: Why does 1470nm remain the "cornerstone" of global vascular surgery guidelines today, despite the continuous emergence of new wavelengths?

I. Triumph of Principle: The "Precision Welding Torch" for the Vein Wall

The core of endovenous laser ablation (EVLA) is using the thermal effect of laser to shrink and close the vein wall. The uniqueness of the 1470nm wavelength lies in its extremely high absorption rate by water molecules. According to the optical model by Hale & Querry, 1470nm is located at a near-infrared absorption peak of water. Upon contacting the water-rich venous intima, the energy is instantly and abundantly absorbed, with strictly limited penetration depth.

This brings two major clinical advantages: first, high energy utilization efficiency, acting directly on the vein wall rather than on hemoglobin in the blood; second, low risk of collateral damage, with less energy conducted to surrounding tissues like the saphenous nerve and skin. Compared to the earlier 980nm laser, 1470nm represents an upgrade from the "blood boiling" mode to the "vein wall welding" mode.

II. Depth of Evidence: Over a Decade of Evidence-Based Accumulation

The reason 1470nm has become the standard protocol unanimously recommended by European and American vascular surgery society guidelines stems from its vast system of evidence-based medicine.

Firstly, the data on closure rates is extremely solid. A 2020 study from Peking University Shenzhen Hospital, involving 248 patients, showed a venous closure rate of over 98% at 6 months post-operation, with patient quality of life scores significantly better than those after traditional surgery.

Secondly, head-to-head comparison with 1940nm has yielded the highest level of evidence. A randomized controlled trial published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders in 2024, involving 216 patients, showed: at 6 months post-operation, the closure rate was 99% in the 1470nm group and 100% in the 1940nm group, with no statistically significant difference; the incidence of adverse events was extremely low in both groups (approximately 1%). The study conclusion clearly states that both lasers provide excellent results in terms of anatomical success rate and safety.

Thirdly, the capability to handle large-diameter vessels has been fully validated. A 2022 study published in Acta Balneologica pointed out that the moderate penetration depth of 1470nm ensures uniform thermal damage across the full thickness of the vein wall, which is key to achieving permanent closure.

III. Objective Examination: How to Understand Postoperative Pain

The slightly higher postoperative pain score for 1470nm compared to 1940nm is a concomitant phenomenon of its efficient closure, not a technical flaw. The aforementioned RCT confirmed that the 1470nm group required higher linear energy density and power settings, with a median of 11.5 days for patients to resume daily activities, longer than the 7 days in the 1940nm group.

Physician experience is the decisive variable. By precisely controlling pullback speed, power, and pulse mode, experienced practitioners can maintain high closure rates while minimizing pain and bruising to very low levels. This is not a technical ceiling but a demand for professional expertise.

IV. Academic Debate: A Prudent View on 1940nm

British phlebology authority Whiteley pointed out in a 2022 review in Surgical Technology International: although 1940nm has a higher water absorption rate, when treating the thicker-walled saphenous vein, there is no evidence that its energy distribution advantage translates into a clinically significant difference; moreover, lower power settings might pose a risk of long-term recanalization.

Schematic Diagram of EVLA Mechanism

Image Source ：A current understanding of endovenous laser thermal ablation. J Vasc Surg Cases Innov Tech, 2024, 10(6): 101587.

Currently, most studies on 1940nm involve short-term follow-up (within 1 year). Whether its 5-year closure rate is non-inferior to 1470nm is still under observation (e.g., the French NEWWAVE trial, expected to be completed in 2031). It is not rigorous to label 1470nm as an "old technology to be replaced" before long-term evidence is available.

V. Conclusion: The Value of the Classic Lies in "Certainty"

In the medical field, "new" does not naturally equal "better," and "classic" does not mean "outdated."

The value of the 1470nm laser is rooted in its definitive physical principles, definitive short-term closure rate, and definitive long-term safety. It is not a loser in the battle between old and new, but rather the cornerstone of minimally invasive varicose vein treatment.

For primary hospitals and departments performing EVLA, 1470nm remains the preferred option with the highest overall cost-effectiveness, the most favorable learning curve, and the most complete evidence-based support. It can handle the vast majority of clinical classifications (C2-C6) while ensuring extremely low complication risks under standardized procedures.

The future direction is not a zero-sum game, but individualized treatment: for those seeking an极致 pain-free experience with suitable vascular conditions, 1940nm is an excellent upgrade option. However, for achieving definitive long-term closure, treating larger-diameter vessels, and ensuring universal applicability in medical insurance coverage, the "gold standard" status of 1470nm will remain unchallenged until 2030.